London-based pre-seed and seed investor that likes to lead rounds with tickets up to £5m across fintech, health, climate, data and AI. Its portfolio page lists new investments in 2025 (Falkin, Chalkie, Jigcar) and 2026 (Bios Life, Onyx, Lateral and others).
Triple Point Ventures backed 1 Y Combinator company.

The world's first digital clinic for substance use management
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.